tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
GSK and iTeos Therapeutics Advance Phase 3 NSCLC Study with Belrestotug and Dostarlimab
PremiumCompany AnnouncementsGSK and iTeos Therapeutics Advance Phase 3 NSCLC Study with Belrestotug and Dostarlimab
7d ago
iTeos Therapeutics Holds Annual Stockholders Meeting
Premium
Company Announcements
iTeos Therapeutics Holds Annual Stockholders Meeting
1M ago
Tim Van Hauwermeiren Resigns from iTeos Board
Premium
Company Announcements
Tim Van Hauwermeiren Resigns from iTeos Board
2M ago
iTeos Therapeutics downgraded to Neutral at Wedbush after wind down decision
PremiumThe FlyiTeos Therapeutics downgraded to Neutral at Wedbush after wind down decision
2M ago
iTeos Therapeutics downgraded to Neutral from Outperform at Wedbush
Premium
The Fly
iTeos Therapeutics downgraded to Neutral from Outperform at Wedbush
2M ago
iTeos Therapeutics Announces Strategic Wind Down Plan
Premium
Company Announcements
iTeos Therapeutics Announces Strategic Wind Down Plan
2M ago
iTeos Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe FlyiTeos Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
2M ago
iTeos Therapeutics downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
iTeos Therapeutics downgraded to Market Perform from Outperform at Leerink
2M ago
Strategic Shift and Strong Financials Position iTeos Therapeutics for Growth
Premium
Ratings
Strategic Shift and Strong Financials Position iTeos Therapeutics for Growth
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100